Association of bullous pemphigoid and comorbid health conditions: a case–control study
| العنوان: | Association of bullous pemphigoid and comorbid health conditions: a case–control study |
|---|---|
| المؤلفون: | Derek Y. Hsu, Sherry Lee, Beatrice Nardone, Supriya Rastogi, Jonathan I. Silverberg |
| المصدر: | Archives of Dermatological Research. 313:327-332 |
| بيانات النشر: | Springer Science and Business Media LLC, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | medicine.medical_specialty, Pemphigoid, integumentary system, Exacerbation, business.industry, Case-control study, Dermatology, General Medicine, Odds ratio, medicine.disease, eye diseases, Obstructive sleep apnea, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Epidemiology, medicine, Bullous pemphigoid, skin and connective tissue diseases, business, Kidney disease |
| الوصف: | Bullous pemphigoid is an autoimmune skin disease characterized by the formation of blisters between the epidermis and dermis. Comorbidities of pemphigoid have not been well-described. Identification of comorbidities associated with pemphigoid is important to decrease morbidity and mortality. To identify the comorbid health conditions of bullous pemphigoid. This was a case–control study of 91 cases of pemphigoid verified by clinical and laboratory diagnosis and 546 age- and sex-matched controls with complete follow-up at a large metropolitan quaternary care medical center. The average age of bullous pemphigoid patients was 76 years and 53% of patients were female. Forty-eight (53%) of the BP patients had a history of inpatient hospitalization, of which 22 (24.2%) were hospitalized for either previously undiagnosed BP or an exacerbation of BP. Bullous pemphigoid was significantly associated with hypertension [adjusted odds ratio (95% confidence interval)]: [2.03 (1.24–3.32)], diabetes mellitus [2.59 (1.60–4.19)], chronic kidney disease [2.29 (1.19–4.40)], end-stage renal disease [3.82 (1.48–9.85)], basal cell carcinoma of the skin [6.00 (1.94–18.6)], and obstructive sleep apnea [5.23 (2.45–11.19)]. 78% of BP patients used at least one systemic immunosuppressant. There was no significant association between treatments for pemphigoid and any of the comorbidities. Bullous pemphigoid patients need screening for comorbid health conditions even though treatment options do not seem to be associated with these comorbidities. |
| تدمد: | 1432-069X 0340-3696 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::e237484afe794346cdf31cf08b4f2474Test https://doi.org/10.1007/s00403-020-02100-2Test |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi...........e237484afe794346cdf31cf08b4f2474 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 1432069X 03403696 |
|---|